Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)
Subtype classification of primary aldosteronism is important but challenging. Increasing evidence has shown that 68Ga-Pentixafor PET/CT imaging which targets CXCR4 is beneficial to the subtype classification of primary aldosteronism. Based on all the available evidence, and after in-depth discussion...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2022-11-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0584 |
| _version_ | 1811177973675458560 |
|---|---|
| author | Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group Chinese Society of Endocrinology PET group Chinese Society of Nuclear Medicine |
| author_facet | Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group Chinese Society of Endocrinology PET group Chinese Society of Nuclear Medicine |
| author_sort | Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group |
| collection | DOAJ |
| description | Subtype classification of primary aldosteronism is important but challenging. Increasing evidence has shown that 68Ga-Pentixafor PET/CT imaging which targets CXCR4 is beneficial to the subtype classification of primary aldosteronism. Based on all the available evidence, and after in-depth discussion of a group of multi-disciplinary experts, a consensus has been established, which covers imaging technology, interpretation of results of CXCR4 imaging, and the guidance to the choice of the treatment and prognosisevaluation. The consensus is helpful for standardizing 68Ga-Pentixafor PET/CT imaging and promoting a better diagnosis procedure in primary aldosteronism. |
| first_indexed | 2024-04-11T06:10:23Z |
| format | Article |
| id | doaj.art-fe6654abd35d488fb26c5c073be21931 |
| institution | Directory Open Access Journal |
| issn | 1674-9081 |
| language | zho |
| last_indexed | 2024-04-11T06:10:23Z |
| publishDate | 2022-11-01 |
| publisher | Editorial Office of Medical Journal of Peking Union Medical College Hospital |
| record_format | Article |
| series | Xiehe Yixue Zazhi |
| spelling | doaj.art-fe6654abd35d488fb26c5c073be219312022-12-22T04:41:18ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812022-11-0113698699110.12290/xhyxzz.2022-0584Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal GroupChinese Society of Endocrinology PET groupChinese Society of Nuclear MedicineSubtype classification of primary aldosteronism is important but challenging. Increasing evidence has shown that 68Ga-Pentixafor PET/CT imaging which targets CXCR4 is beneficial to the subtype classification of primary aldosteronism. Based on all the available evidence, and after in-depth discussion of a group of multi-disciplinary experts, a consensus has been established, which covers imaging technology, interpretation of results of CXCR4 imaging, and the guidance to the choice of the treatment and prognosisevaluation. The consensus is helpful for standardizing 68Ga-Pentixafor PET/CT imaging and promoting a better diagnosis procedure in primary aldosteronism.https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0584primary aldosteronismcxcr4 receptor68ga-pentixafor pet/ctexpert consensus |
| spellingShingle | Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group Chinese Society of Endocrinology PET group Chinese Society of Nuclear Medicine Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022) Xiehe Yixue Zazhi primary aldosteronism cxcr4 receptor 68ga-pentixafor pet/ct expert consensus |
| title | Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022) |
| title_full | Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022) |
| title_fullStr | Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022) |
| title_full_unstemmed | Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022) |
| title_short | Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022) |
| title_sort | consensus on clinical application of the cxcr4 targeted imaging in the diagnosis of primary aldosteronism 2022 |
| topic | primary aldosteronism cxcr4 receptor 68ga-pentixafor pet/ct expert consensus |
| url | https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2022-0584 |
| work_keys_str_mv | AT chineseurologicaldoctorassociationadrenalhypertensionsurgerycollaborativeorganizationadrenalgroup consensusonclinicalapplicationofthecxcr4targetedimaginginthediagnosisofprimaryaldosteronism2022 AT chinesesocietyofendocrinologypetgroup consensusonclinicalapplicationofthecxcr4targetedimaginginthediagnosisofprimaryaldosteronism2022 AT chinesesocietyofnuclearmedicine consensusonclinicalapplicationofthecxcr4targetedimaginginthediagnosisofprimaryaldosteronism2022 |